BRNS

Companies
NASDAQ
Barinthus Biotherapeutics Pte Ltd.
Health Care
Price Chart
Overview

About BRNS

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Market Cap
$77.7M
Volume
23.0K
Avg. Volume
30.6K
P/E Ratio
-0.47222224
Dividend Yield
0.00%
Employees
119.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.59
Low Correlation
Volatility
High (0.92)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BRNS.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BRNS shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$77.7M
Volume23.0K
P/E Ratio-0.47
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how BRNS fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025